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cause this analysis is restricted to patients on PD, it would bePreservation of glomerular filtration rate on dialysis when ad-
scientifically incorrect to interpret previous studies solely onjusted for patient dropout.
the basis of the results from this analysis.Background. Residual renal function (RRF) plays an impor-
Conclusion. In any longitudinal study designed to estimatetant role in dialysis patients. Studies in patients on maintenance
trends in an outcome measured over time, it is important thatdialysis suggest that RRF is better preserved in patients receiv-
the analysis of the data takes into account any effect patienting peritoneal dialysis (PD) vis-a`-vis those receiving hemodialy-
dropout may have on the estimated trend. This analysis demon-sis (HD). We speculated that regardless of the patient’s type
strates that among PD patients, both the starting GFR and theof therapy, the estimate obtained for the rate of decline in
rate of decline in GFR are associated with patient dropout.glomerular filtration rate (GFR) may be biased because of
Consequently, future studies aimed at estimating the rate ofinformative censoring associated with patient dropout. Infor-
decline in GFR among PD patients should also account formative censoring occurs when patients who die or transfer to
any dependencies between dropout and GFR. Similarly, dataanother modality very early have associated with them a lower
analyzing for apparent differences in the rate of decline ofstarting GFR or a higher rate of decline of GFR than patients
GFR between PD and HD should also adjust for possiblewho either complete the study or who die or transfer much
informative censoring.later. If patient dropout is indeed related to the rate of decline
in GFR and if this relationship is ignored in the analysis, then
the estimate obtained of the rate of decline in GFR may be
biased. A natural progression of the disease process in patients
Methods. In an attempt to determine if there is a relationship
with chronic renal failure often leads to an inexorablebetween patient dropout and the decline in GFR, we reana-
decline in residual renal function (RRF), eventually lead-lyzed the CANUSA data by modeling GFR as a nonlinear
function of time with the rate of decline being exponential. ing to either dialysis or transplantation. A residual renal
Results. This article highlights the significance of “informa- creatinine clearance of 1 mL/min translates into a weekly
tive censoring” when studying the decline of RRF on dialysis. creatinine clearance of 10 L. It is obvious that the contri-
The results show that for the CANUSA cohort, the mean
bution of RRF to overall small solute and water clear-initial GFR was significantly lower, and the rate of decline was
ance is important during the initial years of dialysis, bothsignificantly higher for patients who died or transferred to HD
in achieving adequacy targets, as well as maintainingthan for patients who were randomly censored or received a
transplant. It is important to emphasize that the impact of appropriate fluid balance. Regardless of the mode of
informative censoring on previous analyses of the decline of dialysis, that is, hemodialysis (HD) or peritoneal dialysis
RRF between PD versus HD is presently unclear. If bias caused (PD), there is usually a gradual decline in RRF withby informative censoring is the same regardless of what therapy
time.a patient is on, then conclusions from previous studies compar-
The rates of decline of RRF on PD and HD have beening the decline in GFR between PD and HD would still be
valid. However, if the magnitude of the bias differs according compared in many studies, and these studies seem to
to therapy, then additional adjustments would be needed to suggest that RRF is better preserved in patients on PD
fairly compare the decline in GFR between PD and HD. Be- than in those patients who are on HD [1–5]. A compara-
tive analysis of RRF between HD and PD patients is
fraught with complexities. The effects of confoundingKey words: residual renal function, informative censoring, patient drop
out, dialysis, analysis of GFR. factors such as case mix, associated comorbidity, use
of nephrotoxic drugs, and hemodynamic stability mayReceived for publication April 21, 1999
influence the rate of decline of glomerular filtration rateand in revised form September 17, 1999
Accepted for publication September 30, 1999 (GFR), thus introducing bias in the final results. More
importantly, previous results regarding the rate of de-Ó 2000 by the International Society of Nephrology
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Table 1. Parameter estimates b0 (starting GFR in mL/min) and b1cline in GFR may be biased by the presence of informa-
(rate parameter in months21) and standard errors from a nonlinear
tively censored data. Informatively censored data occur mixed-effects model relating GFR to cause of drop out
when the probability of patient dropout is related to the
Parameter Event N (%) Estimate SEunderlying rate of decline in GFR and hence to the
b0 mL/min Censored 322 (50.0%) 4.08 0.150underlying values of GFR. When this occurs, we must
Died 79 (12.3%) 3.60 0.308
somehow account for the pattern of missing data in our Transfer 110 (17.1%) 3.70 0.260
Transplant 133 (20.7%) 4.40 0.235analysis because otherwise, those patients who complete
b1 months21 Censored 322 (50.0%) 0.0329 0.0041the study could unfairly weight the results of the analysis.
Died 79 (12.3%) 0.0709 0.0114
This, in turn, can produce estimates from a regression Transfer 110 (17.1%) 0.0688 0.0104
Transplant 133 (20.7%) 0.0381 0.0073analysis that either underestimate or overestimates the
mean starting GFR and/or rate of decline in GFR. In
contrast, when the rate of decline in GFR is independent
of patient dropout or, vice versa, patient dropout is inde-
pendent of GFR, then subsequent missing values of GFR starting GFR at initiation of dialysis. b1i is the patient’s
rate of decline in GFR, and eij is random within-patientare said to be missing at random, and we can safely
ignore the missing data in our analysis. error. Using nonlinear regression techniques described
in the Appendix, initially the data were fit to the modelWe selected the CANUSA cohort as a representative
PD population to study the phenomenon of informative to determine if there are any effects of patient age, cause
of dropout (death, transfer to HD, transplant), and/orcensoring in monitoring the rate of decline in GFR [6].
In this study, GFR was estimated as the average of urea time to dropout on the average starting GFR or on the
average rate of decline in GFR. To that end, only thoseand creatinine residual renal clearance and was mea-
sured periodically over the course of the study. Informa- patients who died, transferred to HD, or received a trans-
plant were included in this initial analysis. The resultstively censored data would occur if PD patients who die
indicate there are no significant effects caused by age oror transfer to HD very early in this study have associated
to time to dropout on either the starting GFR or thewith them a lower starting GFR and/or higher rate of
rate of decline in GFR (P 5 0.48067 based on a likelihooddecline than those who either complete the study or who
ratio chi square of 7.53 on 8 degrees of freedom). How-die or transfer to HD much later.
ever, the cause of dropout (that is, death vs. transfer toIn an effort to determine whether patient dropout
HD vs. transplant) was significantly associated with theleads to informative censoring when estimating the rate
starting GFR and on the subsequent decline in GFRof decline in GFR, we reanalyzed the CANUSA data
(P , 0.001). Consequently, we fit the data a second timeusing a conditional nonlinear mixed-effects model. The
in which we excluded the effects of age and time todecline in GFR was modeled as a nonlinear function
dropout as covariates, but we included those patientsof time, taking into account the possibility that missing
who were randomly censored at the end of the study asvalues of GFR may be associated with patient dropout
a fourth patient group. Patients were classified as cen-(death, transfer to another modality, or transplantation).
sored if they either (a) completed the two years of follow-If patient dropout is indeed related to the rate of decline
up study and were still on PD at the end of the study,in GFR but is ignored in the analysis, then the results
or (b) were randomly censored (for example, staggeredof the analysis may be biased.
entries or lost to follow-up) prior to the completion of
the study.
METHODS
In our analysis, we excluded all patients who were
RESULTSanuric at baseline (that is, any patient with a baseline
The results of fitting the exponential decay model areGFR 5 0). This reduced the sample size from the 680
presented in Table 1. Based on this model, the parameterincident PD patients (originally enrolled in CANUSA)
estimates describe what the average patient’s GFR re-to 644 patients. Based on these 644 patients, we modeled
sponse profile looks like as a function of follow-up status.GFR as a function of time using methods similar to those
Although time to dropout was not significantly associ-described by Lysaght et al [5]. Specifically, we used an
ated with the decline in GFR, those patients who diedexponential decay model to fit GFR as a function of
or were transferred to HD did exhibit a significantlytime on dialysis. For the ith patient, the exponential decay
lower starting GFR [that is, b0 (mL/min)] than those whomodel is given by
were censored or transplanted (P 5 0.0162). Likewise,
GFRij 5 b0i exp(2b1i 3 tij) 1 eij patients who died or were transferred to HD had a sig-
nificantly higher rate of decline in GFR [that is, b1 (1where GFRij is the measured GFR for the ith patient at
the jth follow-up time, tij. b0i is the ith patient’s estimated per month)] than those who were randomly censored or
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Fig. 3. Observed and predicted GFRs (mL/min) for those patients who
Fig. 1. Observed and predicted glomerular filtration rates (GFRs; received a transplant. Symbols are: (h) the mean GFRs of those who
mL/min) for those patients who died. Symbols are: (h) the mean GFRs transplanted in the first year; (s) the mean GFRs of those who trans-
of those who died in the first year; (s) the mean GFRs of those who planted in the second year; (*) the mean GFRs of those who trans-
died in the second year; (*) the mean GFRs of those who died after planted after two years; (d) the mean GFRs across all patients who
two years; (d) the mean GFRs across all patients who died. The solid received a transplant. The solid line denotes predicted values.
line denotes predicted values.
Fig. 2. Observed and predicted GFRs (mL/min) for those patients who Fig. 4. Observed and predicted GFRs (mL/min) for those patients who
transferred to hemodialysis (HD). Symbols are: (h) the mean GFRs were randomly censored. Symbols are: (h) the mean GFRs of those
of those who transferred in the first year; (s) the mean GFRs of those who were censored in the first year; (s) the mean GFRs of those who
who transferred in the second year; (*) the mean GFRs of those who were censored in the second year; (*) the mean GFRs of those who
transferred after two years; (d) the mean GFRs across all patients who were censored after two years; (d) the mean GFRs across all patients
transferred. Solid line denotes predicted values. who were censored. The solid line denotes predicted values.
transplanted (P , 0.001). There were no statistically For example, from Figure 1, it is evident that there is
significant differences in the starting GFRs (that is, b0) no apparent trend or pattern or difference in the mean
nor in the GFR decay rates (that is, b1) between those GFR values between the open squares (those who diedpatients who died and those who transferred to HD.
in the first year of follow-up), the open circles (thoseSimilarly, there were no statistically significant differ-
who died in the second year of follow-up), the starsences between those who received a transplant and those
(those who died after the second year of follow-up), andwho were randomly censored.
the solid dots (all patients who died, regardless of whenFigures 1 to 4 illustrate what the average patient’s
they died). All of these points fit reasonably well withGFR response profile looks like based on whether the
the solid curve, which is the predicted GFR curve forpatient subsequently died, transferred to HD, received
the average patient who died. The predicted curve isa transplant, or was randomly censored. Included are
obtained from Table 1 directly. For example, in Figurethe observed mean GFRs, both overall and by select
1, the solid curve depicts the relationship between GFRintervals within which the event took place. The different
and time on therapy (in months) for those who died:mean GFR values (0 to 12 months, 13 to 24 months,
that is, GFR 5 3.60 3 exp (20.0709 3 months).251 months, overall) are presented to illustrate the fact
The observed GFRs of patients who died or trans-that for the CANUSA data, the time to dropout was not
ferred to HD fit reasonably well with their respectivestatistically significantly associated with the decline in
GFR over time for each of the four types of outcomes. predicted curves. Similar trends were observed for the
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two years of dialysis, but it also overestimates the rate
of decline among patients who either completed the
study or received a transplant. Because patients who
dropped out because of transplantation are similar to
those who completed the study, there is a bit of a cancel-
lation effect between those who received a transplant
(higher GFRs with shorter follow-up times) versus those
who died or transferred (lower GFRs with shorter fol-
low-up times). Thus, in this study, two competing mecha-
nisms were found under which informative censoring
takes place. On one hand, we have long-term patients
(that is, those who completed the study or who were
randomly censored) who are more likely to have higher
GFRs than those who drop out because of death or
technique failure (on average), whereas on the other
Fig. 5. Observed and predicted GFRs (mL/min) for all patients ac- hand, those patients who drop out because of trans-
cording to the cause of dropout. Symbols are: (d) the mean GFRs of
plantation are likely to have higher GFRs than thosethose who died; (s) the mean GFRs of those who transferred to another
modality; (h) the mean GFRs of those who were transplanted; (*) the who die or transfer to HD. It is not clear what impact
mean GFRs of those who were censored. The predicted values for each this cancellation effect between dropouts who receive a
cause of modality are: (—) patient death; (— — —) transfer to another
transplant versus those who die or transfer to HD willmodality; (- — - —) patient transplanted; (- - -) patient censored.
have on comparisons between PD and HD. However, it
is clear that similar analyses are needed for HD patients.
More importantly, studies comparing PD with HD that
patients who were either censored or transplanted take into account the possible effects of informative cen-
(Fig. 5). soring are also needed. Some caution is in order when
interpreting the results of our analysis. First, there may
be other factors not included in this analysis that mayDISCUSSION
explain the current findings. For example, unmeasured
Our results show that in the CANUSA study, the comorbid conditions and/or disease severity and the use
initial GFR of patients who either died or transferred of nephrotoxic agents are some of the factors that may
to HD was significantly lower than patients who either explain why the patients who died or transferred had,
completed the study or were transplanted. The analysis on average, a lower starting GFR and a higher rate of
also shows that the rate of decline of GFR in these groups decline of GFR than those who were either censored or
of patients was higher than those who either completed transplanted. More importantly, because the follow-up
the study or were transplanted. To our knowledge, this in this study was only two years for most patients, the
is the first attempt to correct for the possible presence limited range of dropout times may well explain why
of informatively censored data when estimating the rate time to dropout was not significantly associated with the
of decline in RRF among PD patients. The results of our rate of decline in GFR. This would help explain why the
analysis suggest that some level of informative censoring type of dropout (death and transfer to HD vs. censored
exists among PD patients, and further studies are clearly and transplant) is predictive of the rate of decline in GFR
needed to determine whether similar informative censor- even though the actual time to dropout is not predictive.
ing occurs in HD patients. Residual renal function contributes a number of posi-
Many patients on PD do maintain a GFR above 2.0 tive physiologic benefits to patients on dialysis [7]. Main-
mL/min beyond 2.5 years of therapy. The removal of tenance of erythropoietin production and vitamin D
patients with lower GFR values than those who continue conversion, better clearance of b2 microglobulin, and re-
does impact on the overall average value for GFR on moval of water and electrolytes by the kidney are some
PD over time. For example, if we were to ignore cause of the benefits of RRF. Small solute clearances provided
of dropout in our analysis and simply fit the model assum- by RRF comprise a significant proportion of the total
ing no informative censoring, we would have estimated small solute clearances over the first two years of the
the average starting GFR to be b0 5 4.02 6 0.107 mL/min therapy [6]. Higher RRF at the initiation of dialysis and
and the average rate parameter describing the decline in while on renal replacement therapy have been docu-
GFR to be b1 5 0.0415 6 0.0033 months21. Compared mented to improve outcomes and reduce patient mortal-
against the values presented in Table 1, this analysis ity [8–10]. Thus, for example, it can be argued that the
underestimates the rate of decline among patients who improved outcome in PD patients recently reported by
the Canadian organ replacement registry may be in parteither died or were transferred to HD within the first
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related to the better preservation of RRF with PD as the problem when comparing two vastly different modal-
compared with HD [11]. However, it may be inaccurate ities like HD and PD. Informative censoring is thus one
to infer this in light of the phenomenon of informative more important confounding factor that needs to be ad-
censoring unless the effect of informative censoring oc- justed for when estimating the rate of decline in GFR
curs equally between PD and HD. The mortality rises for a group of patients or when modality comparisons
with the decline in RRF [6, 12, 13]. All such evidence (HD vs. PD) in GFR are being made.
in relationship to RRF has most likely influenced the An accurate analysis of this important issue can be
recently released DOQI guidelines [14], which recom- settled only by a prospective, randomized, and controlled
mend initiation of dialysis at a GFR of 10.5 mL/min/ trial that adjusts for all known confounding factors
1.73 m2. through randomization and that also adjusts for possible
The issue of examining preservation of RRF is equally, informative censoring through the use of conditional
if not more, complex than the analysis of mortality be- nonlinear mixed-effects regression. The randomization
tween PD and HD. It therefore becomes imperative that of patients to a particular dialysis modality is a difficult
any analysis of GFR and its comparison between HD and issue, and therefore, initiating such a trial seems some-
PD takes into account the phenomenon of informative what difficult to achieve. In the absence of a randomized
censoring apart from a variety of other confounding fac- trial, a well-designed prospective longitudinal trial of
tors such as age, sex, race, comorbidity, the nature of both PD and HD patients with adequate case-mix adjust-
renal disease, and the use of nephrotoxic drugs. Also, ment, as well as adjustment for informative censoring,
while making comparisons of RRF between the two dia- will help us to understand this complex issue better. Such
lytic modalities, it is important to be careful insofar as a study will enable us to determine whether the effect
the measurement of RRF is concerned. Creatinine clear- of informative censoring is the same or not between the
ance as a determinant of the GFR may overestimate two modalities.
GFR in chronic renal failure caused by the tubular secre- This study does not provide any evidence regarding
tion of creatinine. It has been recommended that al- the validity/invalidity of previous studies comparing the
though creatinine clearance with 800 mg of cimetidine decline of RRF between PD versus HD. Extrapolation
daily most closely approximates GFR for CAPD patients of the findings reported in this article to other studies
[15], the mean of urea and creatinine clearance without may be scientifically inaccurate. This question can only
cimetidine also approximates GFR measured by inulin be answered by a properly conducted trial as mentioned
clearance [16]. earlier in this article. Until such a trial is done, drawing
Several hypothetical reasons have been mentioned for any firm conclusions regarding RRF and the better pres-
an apparent better preservation of GFR in patients on ervation thereof (on PD), should be tempered especially
PD. The one most commonly cited is better hemody- in lieu of these findings that indicate there is a need to
namic stability on PD [7]. The decline of GFR can be adjust for the presence of informative censoring.
accelerated by poor blood pressure control, aminoglyco-
Reprint requests to Karl D. Nolph, M.D., Division of Nephrology,side exposure, contrast, and other nephrotoxic drugs,
Department of Internal Medicine, University of Missouri-Columbia,including nonsteroidal anti-inflammatory agents. Within MA436 Health Sciences Center and Dalton Research Center, Columbia,
the CANUSA study and all other studies in the litera- Missouri 65212, USA.
E-mail: nolphk@health.missouri.eduture, these may be far more important than the dialysis
modality. PD dropouts may have been sicker patients
getting more nephrotoxic drugs, more contrast, suffering
more infections and/or having problems with hyperten-
APPENDIXsion or hypotension. Thus, low GFR may not be the
The decline in GFR over time was modeled using acause of dropout in many patients as much as the factors
two-stage nonlinear mixed-effects model. If there is nothat lead to dropout (resulting in insults to the GFR).
informative censoring of the data, the two-stage modelHowever, the major point of our analysis is that none
is given by:of the previously mentioned and subsequent studies (ab-
stract; J Am Soc Nephrol 9:226A, 1998) [1–5, 17] have Stage 1: GFRij 5 b0i exp(2b1i 3 tij) 1 eij
addressed the issue of informative censoring when esti-
Stage 2: b0i 5 b0 1 b0imating or comparing the decline of GFR among patients
on PD and/or HD. In contrast, it has been speculated b1i 5 b1 1 b1ithat given the large amount of available literature, incor-
where GFRij is the measured GFR for the ith patient atporating various experimental designs, it is highly un-
the jth follow-up time. b0i is the ith patient’s estimatedlikely that such results are due to such a selection bias
GFR at initiation of dialysis. b1i is the patient’s rate of[18]. Our results relating to the presence of informative
censoring in PD patients underscore the complexity of decline in GFR, and eij is the random within-patient
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CAPD-A decade of experience, in Contributions to Nephrologyerror. In the second stage, the patient-specific parame-
(vol 89), edited by la Greca G, Olivares J, Feriani M, Passlick-
ters, b0i and b1i, are assumed to be normally distributed Deetjen J, Basel, Karger, 1991, pp 16–27
3. Rottembourg J, Issad B, Poiganet JL, Strippoli P, Balducci A,with overall means, b0 and b1, and random between-
Slama G, Gahl GM: Residual renal function and control of bloodpatient error, b0i and b1i. glucose levels in insulin dependent diabetic patients treated by
To test for possible informative censoring, we initially CAPD, in Prevention and Treatment of Diabetic Nephropathy,
edited by Keen H, Legrain M, MTP Press, Boston, 1983, ppincluded patient age as a baseline covariate as well as
339–359the cause of dropout (death, transfer to HD, transplant)
4. Cancarini GC, Brunori G, Camerini G, Brassa A, Manili L,
and the time to dropout as conditional event-time covari- Maiorca R: Renal function recovery and maintenance of residual
diuresis in CAPD and hemodialysis. Perit Dial Bull 6:77–79, 1986ates. The modified second stage of this conditional model
5. Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm(conditional on the time to drop out) looks like this:
B, Nolph KD, Pollock CA, Prowant B, Farrell PC: The influ-
ence of dialysis treatment modality on the decline of remainingModified b0i 5 b01 3 G1i 1 b02 3 G2i 1 b03 3 G3i 1 b04 3 Agei
residual renal function. ASAIO Trans 37:598–604, 1991
6. CANADA-USA: Peritoneal dialysis study group. Adequacy ofStage 2: 1 b05 3 G1i 3 Ti 1 b06 3 G2i 3 Ti 1 b07 3 G3i 3 Ti 1 b0i
dialysis and nutrition in continuous peritoneal dialysis: Association
with clinical outcomes. J Am Soc Nephrol 7:198–207, 1996b1i 5 b11 3 G1i 1 b12 3 G2i 1 b13 3 G3i 1 b14 3 Agei
7. Rottembourg J: Residual renal function and recovery of renal
function in patients treated by CAPD. Kidney Int 43(Suppl1 b15 3 G1i 3 Ti 1 b16 3 G2i 3 Ti 1 b17 3 G3i 3 Ti 1 b1i
40):S106–S110, 1993
8. Jungers P, Zingraff J, Albouze G, Chauveau P, Page B: Latewhere G1i, G2i, and G3i are coded variables denoting, referral to maintenance dialysis: Detrimental consequences.
respectively, whether a patient died (G1i 5 1 if the ith Nephrol Dial Transplant 8:1089–1093, 1993
9. Tattersall J, Greenwood R, Farrington K: Urea kinetics andpatient died, G1i 5 0 otherwise), transferred to HD
when to commence dialysis. Am J Nephrol 15:283–289, 1995(G2i 5 1 if the ith patient transferred to HD, G2i 5 0 10. Bonomini V, Feletti C, Scolari MP, Stefoni S: Benefits of early
otherwise), or was transplanted (G3i 5 1 if the ith patient initiation of dialysis. Kidney Int 28(Suppl 17):S57–S59, 1985
11. Fenton SSA, Schaubel DE, Desmeulers M, Morrison HI, Maoreceived a transplant, G3i 5 0 otherwise) and where
Y, Copleston P, Jeffery JR, Kjellstrand CM: Hemodialysis ver-Ti is the time to dropout for the ith patient. Following sus peritoneal dialysis: A comparison of adjusted mortality rates.
Follmann and Wu [19] and Hogan and Laird [20], we Am J Kidney Dis 30:334–342, 1997
12. Ravid M, Lang R, Robson M: The importance of daily urine, andinitially fit this conditional model only for those patients
residual renal function in patients treated with chronic hemodialy-who died, transferred to HD, or were transplanted be- sis. Dial Transplant 9:763–765, 1985
cause the exact time to dropout is known for these pa- 13. Merkus MP, Jager KJ, Dekker FW, Boeschoten EW, Steven P,
Krediet RT, the NEOSCAD Study Group: Quality of life intients. Estimates of the regression parameters were ob-
patients on chronic dialysis: Self assessment 3 months after thetained using a conditional pseudo-maximum likelihood start of treatment. Am J Kidney Dis 29:584–592, 1997
estimation procedure described by Vonesh and Chin- 14. NKF-DOQI: Clinical practice guidelines on peritoneal dialysis ade-
quacy. Am J Kidney Dis 30(Suppl 2):S67–S136, 1997chilli [21]. Results of this analysis showed no significant
15. van Olden RW, Krediet RT, Struijk DG, Arisz L: Measurementeffect caused by age or time to dropout on the decline of residual renal function in patients treated with continuous ambu-
latory peritoneal dialysis. J Am Soc Nephrol 7:745–750, 1995of GFR. A second analysis was then run in which age
16. Porile JL, Spiegel DM: Cimetidine improves accuracy of clearanceand time to dropout were excluded from the model, but
measurements in peritoneal dialysis patients. Perit Dial Int 14:309–
we included censored patients as a fourth group. It is 311, 1994
17. Lameire N, Van Biesen W: The impact of residual renal functionthe results of this second model that are summarized in
on the adequacy of peritoneal dialysis. Perit Dial Int 17(Supplthe text of this article.
2):S102–S110, 1997
18. Lysaght MJ: Preservation of residual renal function in mainte-
nance dialysis patients. Perit Dial Int 16:126–127, 1996REFERENCES
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